New inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) are disclosed, as well as processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy.
本发明揭示了具有一般式(I)的p38丝裂原活化蛋白激酶的新
抑制剂,以及它们的制备过程,包括它们的药物组成物和在治疗中的使用。